Moelis & Company Announces the Appointment of Jon Hammack as a Managing Director Providing Strategic Advice to Medical Technology Clients
Moelis & Company, the global independent investment bank, today announced the appointment of Jon Hammack as a Managing Director responsible for providing strategic advice to medical technology clients globally. Based in New York, he joins the Firm on November 11.
Mr. Hammack joins Moelis & Company from Morgan Stanley where he was responsible for the Medical Technology practice. Previously, he worked in the Healthcare Investment Banking Groups at Credit Suisse and Bank of America.
Rick Leaman, Managing Partner at Moelis & Company, said, “We expect to see significant activity in the medical technology space as companies better position themselves for growth and adapt to the evolving healthcare landscape. Clients looking for independent, expert and innovative advice will benefit from Jon’s experience and focus.”
Mr. Hammack’s hire complements the Firm’s existing healthcare coverage effort in services, life sciences, diagnostics, pharmaceuticals and biotechnology.
About Moelis & Company
Moelis & Company is a leading global independent investment bank that provides financial advisory, capital raising and asset management services to a broad client base including corporations, institutions and governments. With 600 employees, Moelis & Company serves its clients around the world through its offices in New York, Beijing, Boston, Chicago, Dubai, Frankfurt, Hong Kong, Houston, London, Los Angeles, Mumbai, Palo Alto, Paris and Sydney. For more information, please visit www.moelis.com.